Advances in cancer immunotherapy suggest that tumor-infiltrating lymphocytes (TILs) are critical for the elimination of tumor cells and maintenance of effective immunosurveillance. Spatial phenotyping ...
A team led by surgeon-scientist Dr. Vinod Balachandran identified the molecular pathway involved in the formation of tertiary lymphoid structures. Therapeutically targeting this pathway could ...
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a ...
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a ...
Please provide your email address to receive an email when new articles are posted on . A machine learning model may aid the detection and classification of tertiary lymphoid structures associated ...
Tertiary lymphoid structures (TLS) are ectopic cellular hubs that coordinate immunity within patient tumors. TLS also correlate with improved prognosis and superior response to immunotherapy. While ...
CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful ...
Novel Model Integrating TME Composition with TLS Gene Signatures Predicts Meaningful Survival Differences in Checkpoint Inhibitor-Treated Patients Cellworks Group Inc., a leader in Personalized ...
The MarketWatch News Department was not involved in the creation of this content. Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback